A new study, “Investigating the Clinical Utility of the Combined Use of Objective and Subjective Measures of ADHD During Treatment Optimization,” found that objective measurement of attention-deficit/hyperactivity disorder (ADHD) symptoms, measured by QbTest, were more sensitive to medication effects than patient self-rating, at both one-month and six-month follow-up visits.
Capturing improvement in twice as many patients
At the first follow up, QbTest activity and inattention measures showed significant effect of medication, compared to the ASRS rating scale, that indicated only moderate effect.
After six months, the QbTest captured 86% of patient’s treatment effects compared with only 37% of patient’s improvement captured by the ASRS rating scale.
The associations between the QbTest and subjective measures increased over time, and importantly, improvements on both measures correlated with improvement in quality-of-life scores.